These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17625243)

  • 1. Zinc balance normalization: an important mechanism of angiotensin-converting enzyme inhibitors and other drugs decreasing the activity of the rennin-angiotensin-aldosterone system.
    Tubek S
    Biol Trace Elem Res; 2007 Mar; 115(3):223-6. PubMed ID: 17625243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in selected zinc metabolism parameters in patients with mild primary arterial hypertension.
    Tubek S
    Biol Trace Elem Res; 2006; 114(1-3):55-63. PubMed ID: 17205987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selected zinc metabolism parameters in relation to insulin, renin-angiotensin-aldosterone system, and blood pressure in healthy subjects: gender differences.
    Tubek S
    Biol Trace Elem Res; 2006; 114(1-3):65-72. PubMed ID: 17205988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme and metals in untreated essential hypertension.
    Ekmekci OB; Donma O; Tunckale A
    Biol Trace Elem Res; 2003 Dec; 95(3):203-10. PubMed ID: 14665725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc supplementation or regulation of its homeostasis: advantages and threats.
    Tubek S
    Biol Trace Elem Res; 2007 Oct; 119(1):1-9. PubMed ID: 17914213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc content in lymphocytes and the activity of zinc ion efflux from lymphocytes in primary arterial hypertension.
    Tubek S
    Biol Trace Elem Res; 2005 Nov; 107(2):89-99. PubMed ID: 16217134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells.
    Laggner H; Hermann M; Esterbauer H; Muellner MK; Exner M; Gmeiner BM; Kapiotis S
    J Hypertens; 2007 Oct; 25(10):2100-4. PubMed ID: 17885553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc: a multipurpose trace element.
    Stefanidou M; Maravelias C; Dona A; Spiliopoulou C
    Arch Toxicol; 2006 Jan; 80(1):1-9. PubMed ID: 16187101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Zinc and arterial pressure].
    Ripa S; Ripa R
    Minerva Med; 1994 Sep; 85(9):455-9. PubMed ID: 7936367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess calcium increases bone zinc concentration without affecting zinc absorption in rats.
    Takasugi S; Matsui T; Omori H; Yano H
    Biol Trace Elem Res; 2007 Jun; 116(3):311-20. PubMed ID: 17709911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular mechanisms of interactions between bioactive peptides and angiotensin-converting enzyme.
    Pan D; Guo H; Zhao B; Cao J
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3898-904. PubMed ID: 21640589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin converting enzyme inhibitors].
    Sramko M; Remko M
    Ceska Slov Farm; 2006 Jul; 55(4):160-7. PubMed ID: 16921734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transporters in the absorption and utilization of zinc and copper.
    Hill GM; Link JE
    J Anim Sci; 2009 Apr; 87(14 Suppl):E85-9. PubMed ID: 18820153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors.
    Galderisi M; de Divitiis O
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):523-31. PubMed ID: 18520954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-9/tissue inhibitors of metalloproteinase-1 expression and atrial structural remodeling in a dog model of atrial fibrillation: inhibition with angiotensin-converting enzyme.
    Zhang W; Zhong M; Yang GR; Li JP; Guo C; Wang Z; Zhang Y
    Cardiovasc Pathol; 2008; 17(6):399-409. PubMed ID: 18706834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Zn, Cu, and Fe on the activity of carbonic anhydrase of erythrocytes in ducks.
    Wu Y; Zhao X; Li P; Huang H
    Biol Trace Elem Res; 2007 Sep; 118(3):227-32. PubMed ID: 17916925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme.
    Pina AS; Roque AC
    J Mol Recognit; 2009; 22(2):162-8. PubMed ID: 18816584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc fluxes and zinc transporter genes in chronic diseases.
    Devirgiliis C; Zalewski PD; Perozzi G; Murgia C
    Mutat Res; 2007 Sep; 622(1-2):84-93. PubMed ID: 17374385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.